BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15990752)

  • 21. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
    Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?
    Papp E; Havasi V; Bene J; Komlosi K; Czopf L; Magyar E; Feher C; Feher G; Horvath B; Marton Z; Alexy T; Habon T; Szabo L; Toth K; Melegh B
    Ann Pharmacother; 2005 Jun; 39(6):1013-8. PubMed ID: 15840736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study.
    Aleksic N; Juneja H; Folsom AR; Ahn C; Boerwinkle E; Chambless LE; Wu KK
    Circulation; 2000 Oct; 102(16):1901-5. PubMed ID: 11034936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Alfonso F; Sabaté M; Fernández C; Stranieri C; Trabetti E; Pignatti PF; Macaya C
    Blood Coagul Fibrinolysis; 2004 Jan; 15(1):89-93. PubMed ID: 15166949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis.
    Floyd CN; Ferro A
    Br J Clin Pharmacol; 2014 Mar; 77(3):446-57. PubMed ID: 23834376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet glycoprotein IIIa gene polymorphism (Leu33Pro) and aspirin resistance in a very elderly Chinese population.
    Wang BY; Tan SJ
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):389-93. PubMed ID: 24720773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
    Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
    Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The relationship between aspirin resistance and endothelial dysfunction in patients with stable coronary artery disease].
    Pamukçu B; Onür I; Oflaz H; Elitok A; Buğra Z; Nişanci Y
    Turk Kardiyol Dern Ars; 2008 Mar; 36(2):103-7. PubMed ID: 18497555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa.
    Szczeklik A; Undas A; Sanak M; Frolow M; Wegrzyn W
    Br J Haematol; 2000 Sep; 110(4):965-7. PubMed ID: 11054089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene.
    Walter DH; Schächinger V; Elsner M; Mach S; Dimmeler S; Auch-Schwelk W; Zeiher AM
    Eur Heart J; 2001 Apr; 22(7):587-95. PubMed ID: 11259146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.
    Mikkelsson J; Perola M; Laippala P; Savolainen V; Pajarinen J; Lalu K; Penttilä A; Karhunen PJ
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2573-8. PubMed ID: 10521390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estradiol increases platelet aggregation in Pl(A1/A1) individuals.
    Boudoulas KD; Montague CR; Goldschmidt-Clermont PJ; Cooke GE
    Am Heart J; 2006 Jul; 152(1):136-9. PubMed ID: 16824843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects.
    Floyd CN; Goodman T; Becker S; Chen N; Mustafa A; Schofield E; Campbell J; Ward M; Sharma P; Ferro A
    Br J Clin Pharmacol; 2014 Aug; 78(2):320-8. PubMed ID: 25099258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death.
    Mikkelsson J; Perola M; Laippala P; Penttilä A; Karhunen PJ
    J Am Coll Cardiol; 2000 Oct; 36(4):1317-23. PubMed ID: 11028489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
    Van der Planken MG; Claeys MJ; Vertessen FJ; Dilling D; Bosmans JM; Berneman ZN; Michiels JJ; Vrints C
    Thromb Res; 2003; 111(3):159-64. PubMed ID: 14678814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin resistance: an evaluation of current evidence and measurement methods.
    Martin CP; Talbert RL
    Pharmacotherapy; 2005 Jul; 25(7):942-53. PubMed ID: 16006273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PlA polymorphism of the glycoprotein IIIa and efficacy of reperfusion therapy in patients with acute myocardial infarction.
    Gorchakova O; Koch W; Mehilli J; von Beckerath N; Schwaiger M; Schömig A; Kastrati A
    Thromb Haemost; 2004 Jan; 91(1):141-5. PubMed ID: 14691579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.